Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depigoid House Dust Mite for moderate to severe atopic eczema
2006-003066-34Phase 3Completed
- Sponsor
- LETI Pharma
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Depigoid Milben Mix with Placebo (2 arms). Primary endpoints: Primary efficacy comparison, Onset of efficacy and 1 more. Started Nov 2006; status: completed.
02
Drugs
Depigoid Mite-Mix
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2006-003066-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003066-34.